[{"id":6265,"regimens":[{"id":12033,"duration":{"id":6031,"approximate_duration":null,"dates_unknown":false},"drug":{"id":8783,"name":"Lopinavir-Ritonavir","url":"cure-api2.ncats.io/v1/drugs/8783","rxNorm_id":null,"notes":null},"use_drug":[{"id":9293,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":12033},{"id":9294,"answer":"In a novel combination with another drug","answer_other":"","regimen":12033}],"created":"2020-10-13T23:29:54.966448Z","updated":"2020-10-13T23:51:43.703718Z","dose":"400/100mg","frequency":"BID","route":"PO","severity":"Inpatient","severity_detail":"","comments":null,"report":6265},{"id":12034,"duration":{"id":6032,"approximate_duration":null,"dates_unknown":false},"drug":{"id":6675,"name":"Ceftriaxone","url":"cure-api2.ncats.io/v1/drugs/6675","rxNorm_id":null,"notes":null},"use_drug":[{"id":9295,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":12034},{"id":9296,"answer":"In a novel combination with another drug","answer_other":"","regimen":12034}],"created":"2020-10-13T23:29:54.974091Z","updated":"2020-10-13T23:51:43.710063Z","dose":"2g","frequency":"QD","route":"PO","severity":"Inpatient","severity_detail":"","comments":null,"report":6265},{"id":12035,"duration":{"id":6033,"approximate_duration":null,"dates_unknown":false},"drug":{"id":5986,"name":"Apremilast","url":"cure-api2.ncats.io/v1/drugs/5986","rxNorm_id":null,"notes":null},"use_drug":[{"id":9297,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":12035},{"id":9298,"answer":"In a novel combination with another drug","answer_other":"","regimen":12035}],"created":"2020-10-13T23:29:54.980310Z","updated":"2020-10-13T23:51:43.715717Z","dose":"30mg","frequency":"BID","route":"PO","severity":"Outpatient","severity_detail":"","comments":null,"report":6265}],"site_of_infection":[],"specific_site":[],"how_outcome":[{"id":8243,"answer":"Clinical assessment","answer_other":"","report":6265},{"id":8244,"answer":"Imaging","answer_other":"","report":6265},{"id":8245,"answer":"PCR","answer_other":"","report":6265}],"how_diagnosis":[{"id":14023,"answer":"Imaging","answer_other":"","report":6265},{"id":14024,"answer":"Clinical assessment","answer_other":"","report":6265},{"id":14025,"answer":"PCR","answer_other":"","report":6265}],"author_username":"Belinda Nhundu","resistant_drugs":[],"combo_drugs":[],"organisms":[{"id":1887,"name":"Severe acute respiratory syndrome coronavirus 2 (sars-cov-2)"}],"disease_name":"COVID-19","author_qualification":"Medical Doctor","author_affiliation":"None","author_country":"","outcome_computed":"Improved","previous_drugs":[],"comments":[],"article_language":"English","why_new_way":[{"id":4312,"answer":"There is no standard/approved therapy for this disease","answer_other":"","report":6265},{"id":4313,"answer":"Co-Infection or Complex Co-morbidities","answer_other":"","report":6265}],"adverse_event_outcome":[],"is_author":false,"cross_linked_diseases":[{"id":396,"name":"Pneumonia"}],"races":[{"id":436,"answer":"White","answer_other":""}],"created":"2020-10-13T23:18:50.051571Z","updated":"2020-10-13T23:51:43.695890Z","title":"COVID-19 pulmonary infection in erythrodermic psoriatic patient with oligodendroglioma: safety and compatibility of apremilast with critical intensive care management.","status":"Approved","anonymous":false,"published":true,"pubmed_id":32385859,"doi":"10.1111/jdv.16625","article_url":"https://pubmed.ncbi.nlm.nih.gov/32385859/","pub_year":2020,"published_authors":"Mugheddu C\r\nPizzatti L\r\nSanna S\r\nAtzori L\r\nRongioletti F","article_author_email":"atzori@unica.it","journal":"Journal of the European Academy of Dermatology and Venereology : JEADV","abstract":"Novel coronavirus 2019 (SARS-CoV2) pandemic has particularly affected Italy, with a profound impact on the therapeutic strategy for complex disorder such as psoriasis, whose extensive skin damage might expose to an increased infective risk compared to the general population.Psoriasis treatment relies on\r\n immunosuppression, and although most experts agree that the benefit-to risk-ratio is in favor of maintaining selective biological therapies, and small molecules such as apremilast, they recommend dismission if severe COVID-19 symptoms occur.","article_type":"Original","study_type":"Case Report","number_of_patients":1,"article_patient_number":"1","full_text_available":true,"outcome":"Patient was cured/recovered","surgery":"No","age":"41-50 years","sex":"Male","ethnicity":"Not Hispanic/Latino","country_contracted":"Italy","country_treated":"Italy","began_treatment_year":"2020","hiv":false,"asthma":false,"lung_disease":false,"diabetes_mellitus":false,"hypertension":false,"cardiovascular_disease":false,"chronic_renal_disease":false,"chronic_liver_disease":false,"immunosuppressant_drugs":true,"intellectual_disability":false,"smoker":false,"other_immunodeficiency":true,"other_comorbid":"Oligodendroglioma","pregnant":false,"unknown":false,"site_of_disease":"Lungs","clinical_syndrome":"Respiratory tract infection","severity":null,"prev_treatment":"","unusual":"","drug_treatment_features":"","have_adverse_events":false,"adverse_events":"","when_outcome":"At the time the treatment was completed","follow_up_period":null,"relapse":"No","reminder":false,"when_reminder":"1 week","additional_info":"Patient with a severe form of psoriasis contracted the COVID-19 pneumonia, while on treatment with apremilast","previously_treated":"","flagged":false,"other_coinfections":"Erythrodermic Psoriasis","disease":630,"drugs":[5986,6675,8783]}]